Earnings Feed
Start Free
|4Apr 16, 2:11 PM ET

Geller Matthew 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Apr 16, 2010

Insider Transaction Report

Form 4
Period: 2010-04-15
BIOSPECIFICS TECHNOLOGIES CORPBSTC
Geller Matthew
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2010-04-15$19.00/sh+15,000$285,000→ 30,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2010-04-15−15,000→ 0 total
    Exercise: $19.00From: 2009-09-21Exp: 2018-09-21→ Common Stock, $.001 par value (15,000 underlying)
  • Exercise/Conversion

    Common Stock

    2010-04-15$19.00/sh+15,000$285,000→ 15,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2010-04-15−15,000→ 15,000 total
    Exercise: $19.00From: 2009-09-21Exp: 2018-09-21→ Common Stock, $.001 par value (15,000 underlying)

Documents

2 files
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

  • EX-24
    exhibit24.htm

    POWER OF ATTORNEY